RPC
ABBV icon

Rossmore Private Capital’s AbbVie ABBV Stock Holding History

Rossmore Private Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Sell
2,000
-200
-9% -$44.4K 0.04% 215
2025
Q4 		$503K Buy
+2,200
New +$501K 0.04% 202

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rossmore Private Capital's ABBV Position: Q1 2026 in Review

Rossmore Private Capital reduced its AbbVie (ABBV) stake by 0.15% in Q1 2026, selling an estimated $15.1K and leaving 46,197 shares worth $10M. The position accounts for 0.88% of the portfolio, ranked #28.

Rossmore Private Capital first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $10.6M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Rossmore Private Capital held 46,197 shares of AbbVie worth $10M as of Q1 2026.
  • Rossmore Private Capital sold 68 AbbVie shares in Q1 2026, an estimated $15.1K.
  • AbbVie made up 0.88% of Rossmore Private Capital's portfolio in Q1 2026, its #28 holding.
  • Rossmore Private Capital first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
  • Rossmore Private Capital's AbbVie position peaked at $10.6M in Q4 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.